These results suggest that female APOE ε4 carriers may experience an earlier saturation of amyloid pathology, which aligns with prior reports of heightened AD risk in females who carry the APOE ε4 allele [51, 52]. The gene discussed is APOE; the disease is Alzheimer disease.